DCF — MOUNTAIN VIEW REG MED CTR
Enterprise Value: $167.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$167.1M
Enterprise Value
$42.5M
PV of Cash Flows
$124.6M
PV of Terminal Value
$200.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $270.1M | $23.0M | 9.0% | $7.5M | $6.8M |
| Year 2 | $278.2M | $26.4M | 10.0% | $9.8M | $8.1M |
| Year 3 | $286.6M | $30.1M | 11.0% | $12.2M | $9.2M |
| Year 4 | $295.2M | $32.5M | 11.0% | $13.7M | $9.4M |
| Year 5 | $304.0M | $34.2M | 11.0% | $14.7M | $9.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $167.1M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$262.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000030505668
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5